Genomic and molecular characterisation of a KPC-producing Klebsiella pneumoniae clinical isolate resistant to meropenem-vaborbactam, imipenem-relebactam, and ceftazidime-avibactam. [PDF]
Wan Y +13 more
europepmc +1 more source
<i>In vitro</i> activity of the novel β-lactamase inhibitor nacubactam against a nationwide collection of carbapenem-resistant Enterobacterales in Japan. [PDF]
Yanagihara K +7 more
europepmc +1 more source
Antimicrobial activity of aztreonam/avibactam and molecular characterization of Enterobacterales not susceptible to ceftazidime/avibactam and/or meropenem/vaborbactam from US medical centres (2016-2024). [PDF]
Sader HS +5 more
europepmc +1 more source
When might we consider using the newer β-lactam agents as empirical therapy against presumed carbapenem-resistant gram-negative infections? [PDF]
Assimakopoulos SF +4 more
europepmc +1 more source
Case Commentary: When one target is not enough-PBP3 insertions and target redundancy in <i>Escherichia coli</i>. [PDF]
Stellfox ME, Doi Y.
europepmc +1 more source
Emergence of KPC-producing <i>Pseudomonas aeruginosa</i> in Spain: insights into an outbreak and resistance to the novel carbapenem/β-lactamase inhibitor combinations imipenem/relebactam and meropenem/vaborbactam. [PDF]
Pérez-Rodríguez G +13 more
europepmc +1 more source
A Comprehensive Review of the Underlying Mechanisms of Resistance and Therapeutic Options for DTR-PA in Bloodstream Infection and Pneumonia: A Clinical Vignette-Based Approach. [PDF]
Maraolo AE +11 more
europepmc +1 more source
Carbapenem-resistant Gram-negative pathogens: molecular epidemiology, diagnostic advances, and emerging therapeutic strategies. [PDF]
Khan M, Patil P, Rathored J.
europepmc +1 more source
<i>In vivo</i> emergence of ceftazidime/avibactam resistance in <i>Pseudomonas aeruginosa</i> driven by OXA-1381, a novel W157L Ω-loop variant of OXA-2. [PDF]
Pérez-Rodríguez G +8 more
europepmc +1 more source
Avibactam-based combinations for the treatment of multidrug resistant Gram-negative bacilli infections. [PDF]
Tiseo G +4 more
europepmc +1 more source

